This might be due to the fact that usually only 3 genes (BMPR2, ACVRL1, ENG) are analysed routinely in PAH patients in a sequential processes, i.e. if one mutation is discovered the other genes are not assessed. Here, ACVRL1 is linked to pulmonary arterial hypertension.